Mar 13, 2020 | Announcements, Kurt Harden, News, Plan Design, Plan Language, Prescription, Preventive Care
As we manage our way through this situation, I want to make sure you know that MedBen has made plans to ensure that we are available for our clients. Many of you and your associates will be even busier during the coming weeks, and we want to make sure that you don’t...
Mar 6, 2020 | Announcements, MedBen Rx, News, Prescription
With the novel coronavirus COVID-19 a constant topic in the news nowadays, many consumers are stocking up on various drugs. MedBen is recommending no change to the current prescription drug refill guidelines for our clients and here’s why: Most wholesalers have a good...
Feb 20, 2020 | Brand Name Drugs, Cost Savings, Generic Drugs, Prescription, Rx Costs, Savings
Generic drugs provide the same high quality as their brand-name equivalents but at substantially lower costs. On average, the price of a generic drug is 80 to 85 percent less than its branded counterpart while meeting the same rigid FDA standards for safety,...
Feb 9, 2020 | Alternative Plan Design, Announcements, Direct-to-Employer Contracting, Government, Health Plan Management, Hospitals, MedBen Rx, MedBen University, Municipalities, Plan Design, Prescription, Private employers, Reference-Based Pricing
Our educational seminar series MedBen University (MBU) offers a range of informative and timely topics about benefit planning. This year’s topics of discussion include: Direct-to-employer contracts and reference-based pricing strategies; Rx solutions that are proven...
Jan 10, 2020 | Cost Savings, MedBen Rx, Prescription, Rx Costs
It is not uncommon for drug manufacturers to raise prescription drug prices at the beginning of the year, and 2020 is no exception. According to new consultancy data, U.S. drug prices increased an average of 5.3 percent on January 1st. Among the common medications...
Jan 7, 2020 | Cancer, Cholesterol, Heart, Prescription, Wellness
According to American Heart Association, about 40 million adults in the U.S. take a statin to lower their cholesterol and reduce the risk for heart disease – and new research suggests that they might also be getting an added anti-cancer benefit. The study found that...
